Innotek Flebodia 600 film-coated tablets 600mg # 18
Category
Diseases of the veins
Scope of the drug
Heart, vessels, blood
Release form
Tablet
Manufacturer country
France
Package quantity, pcs
eighteen
Release form
Film-coated tablets.
Packaging
18 pcs per pack
pharmachologic effect
The drug has a phlebotonic effect (reduces vein distensibility, increases venous tone (dose-dependent effect), reduces venous congestion), improves lymphatic drainage (increases the tone and frequency of contraction of lymphatic capillaries, increases their functional density, reduces lymphatic pressure), improves microcirculation (increases capillary resistance (dose-dependent effect), reduces their permeability), reduces the adhesion of leukocytes to the venous wall and their migration to paravenous tissues, improves oxygen diffusion and perfusion in the skin tissue, has an anti-inflammatory effect.
Strengthens the vasoconstrictor effect of adrenaline, norepinephrine, blocks the production of free radicals, the synthesis of prostaglandins and thromboxane.
Indications
As part of complex therapy:
- to eliminate the symptoms of lymphovenous insufficiency of the lower extremities: a feeling of heaviness or fatigue in the legs, pain
- additional treatment for microcirculation disorders:
- symptomatic therapy of acute hemorrhoids.
Contraindications
Hypersensitivity to the components of the drug, the period of breastfeeding, children under 18 years of age, pregnancy (I trimester) (experience of use is limited).
Application during pregnancy and lactation
Until now, in clinical practice, there have been no reports of any side effects when using the drug in pregnant women.
Application during pregnancy in the II and III trimesters is possible only as directed by a doctor in cases where the expected benefit to the mother outweighs the potential risk to the fetus.
In experimental studies, there was no teratogenic effect on the fetus.
During breastfeeding, it is not recommended to take the drug, because
there is no data on the penetration of the drug into breast milk.
special instructions
Treatment of an acute attack of hemorrhoids is carried out in combination with other drugs, in the absence of a quick clinical effect, it is necessary to conduct an additional examination and adjust the therapy.
Impact on the ability to drive vehicles
There is no data on the negative effect of the drug on the ability to drive vehicles and other mechanisms.
Structure
Active substance:
Diosmin on a dry matter basis 600 mg
Excipients:
talc 10.24 mg, colloidal silicon dioxide 3.5 mg, stearic acid 50.05 mg, microcrystalline cellulose up to 910 mg
Film casing composition:
Sepifilm 002 (hypromellose (E 464) - 9.832 mg, microcrystalline cellulose - 7.866 mg, macrogol 8 stearate type 1 - 1.967 mg).
Sepisps® AR 5523 pink (propylene glycol - traces, hypromellose (E 464) - 0.458 mg, titanium dioxide (E 171) -4.026 mg, crimson dye [Ponso 4R] (E 124) - 0.401 mg, iron oxide black (E 172) - 0.130 mg, iron oxide red (E 172) - 0.020 mg).
Opaglos 6000 (carnauba wax (E 903) - 0.075 mg, beeswax (E 901) - 0.075 mg, shellac (E 904) - 0.150 mg, ethanol 95 ° - traces).
Method of administration and dosage
Before using the drug, you should consult your doctor.
The drug is intended for oral administration.
With varicose veins of the lower extremities and chronic lymphovenous insufficiency (edema, pain, convulsions), 1 tablet is prescribed per day in the morning on an empty stomach.
The duration of therapy is usually 2 months.
With an exacerbation of hemorrhoids, the drug is prescribed 2-3 tablets per day with meals for 7 days.
If one or more doses of the drug are missed, it is necessary to continue using the drug as usual and at the usual dose.
Side effects
In rare cases, hypersensitivity to the components of the drug, requiring a break in treatment: from the gastrointestinal tract - dyspeitic disorders (heartburn, nausea, abdominal pain), from the central nervous system - headache.
If any of the side effects indicated in the instructions are aggravated, or you notice any other side effects not listed in the instructions, inform your doctor.
Drug interactions
No clinically significant interactions with other drugs have been described.
Overdose
Overdose symptoms are not described.
Storage conditions
Store at a temperature not exceeding 30 ° C.
Keep out of the reach of children.
Shelf life
3 years.
Do not use after the expiration date.
Active substance
Diosmin
Name ENG
PHLEBODIA 600
Clinical and pharmacological group
Venotonic drug
ATX code
Diosmin
Dosage
600mg
Structure
Active ingredient: Diosmin in terms of dry substance 600 mg. Excipients: talc 10.24 mg, colloidal silicon dioxide 3.5 mg, stearic acid 50.05 mg, microcrystalline cellulose up to 910 mg. Film composition: Sepifilm 002 (hypromellose (E 464) - 9.832 mg, microcrystalline cellulose -7.866 mg, macrogol 8 stearate type 1 - 1.967 mg).
Sepisps® AR 5523 pink (propylene glycol - traces, hypromellose (E 464) - 0.458 mg, titanium dioxide (E 171) -4.026 mg, crimson dye [Ponso 4R] (E 124) - 0.401 mg, iron oxide black (E 172) - 0.130 mg, iron oxide red (E 172) - 0.020 mg) Opaglos 6000 (carnauba wax (E 903) - 0.075 mg, beeswax (E 901) - 0.075 mg, shellac (E 904) - 0.150 mg, ethanol 95 ° - traces).
Indications
As part of complex therapy: - to eliminate the symptoms of lymphovenous insufficiency of the lower extremities: a feeling of heaviness or fatigue in the legs, pain - additional treatment in case of microcirculation disorders: - symptomatic therapy of acute hemorrhoids.
Contraindications
Hypersensitivity to the components of the drug, the period of breastfeeding, children under 18 years of age, pregnancy (I trimester) (experience of use is limited).
Storage conditions and periods
At a temperature not higher than 30 degrees.
Expiration date: 3 years
INN / Active ingredient
Diosmin
Specifications
Category
Diseases of the veins
Scope of the drug
Heart, vessels, blood
Release form
Tablet
Manufacturer country
France
Package quantity, pcs
eighteen
Scope of application
Cardiology
,
Phlebology
Minimum age from
18 years
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
INNOTECH
The amount of the dosage form in the primary package
18 pcs.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Angioprotective agent
Anatomical and therapeutic characteristics
C05CA03 Diosmin
Dosage form
Film-coated tablets
Dosage (volume) of the substance in the preparation
1 tablet contains: diosmin 600 mg
Expiration date in days
1095
The target audience
Adult
Package weight, g
thirty
Mode of application
:
Before using the drug, you should consult a doctor. < br> The drug is intended for oral administration. < br> With varicose veins of the lower extremities and chronic lymphovenous insufficiency (edema, pain, convulsions), 1 tablet is prescribed per day in the morning on an empty stomach.
The duration of therapy is usually 2 months.
With an exacerbation of hemorrhoids, the drug is prescribed 2-3 tablets per day with meals for 7 days.
If one or more doses of the drug are missed, you must continue to use the drug as usual and at the usual dose. < br>
Information on technical characteristics, delivery set, country of manufacture